GoodRx Holdings, Inc. 8-K

What Happened
GoodRx Holdings, Inc. (GDRX) filed an 8-K on March 27, 2026 (Item 5.02) announcing that Romin Nabiey submitted his resignation as Chief Accounting Officer, effective April 3, 2026. Mr. Nabiey will remain employed through June 8, 2026 to help transition his responsibilities. The company stated the resignation was not due to any disagreement with the company on matters related to operations, policies, or practices.

Key Details

• Resignation submitted March 24, 2026; effective April 3, 2026.
• Nabiey to remain an employee through June 8, 2026 to support transition.
• Company confirmed resignation was not the result of any disagreement with management.
• 8-K signed by Christopher McGinnis, Chief Financial Officer & Treasurer, and filed March 27, 2026.

Why It Matters
A Chief Accounting Officer departure is relevant to investors because the role is central to financial reporting, internal controls, and preparation of earnings and quarterly results. The company’s stated transition timeline and the note that there was no disagreement reduce immediate governance concerns, but investors should watch for announcements about an interim or permanent replacement and any potential impacts on financial reporting or audit processes.